Collegium Pharmaceutical (COLL) Stock Chart & Stock Price History $29.69 -0.68 (-2.24%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$29.69 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Collegium Pharmaceutical Stock Price Performance The Collegium Pharmaceutical (COLL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 6.87%, with a year-to-date return of 3.63%. In the past month, the stock has increased 0.44%, reflecting recent market activity. As of the latest close, Collegium Pharmaceutical traded at $29.69 with a market cap of $954.00 million and volume of 362,917 shares. Five years ago, the stock traded at $17.39, representing a 70.73% increase over that period. At the time, it had a market cap of $604.38 million and a volume of 898,200 shares. Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.69%1 Month Performance+0.44%3 Month Performance+0.20%Year-To-Date Performance+3.63%1 Year Performance-6.87%5 Year Performance+70.73% COLL Stock Chart for Thursday, June, 12, 2025 COLL Chart by TradingView Collegium Pharmaceutical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$30.37$29.69-2.24%$30.59$29.64362,917 shs$954.00 million06/10/2025$30.44$30.37-0.23%$30.93$30.34223,207 shs$975.85 million06/09/2025$30.20$30.44+0.79%$30.87$30.01360,727 shs$978.10 million06/06/2025$29.50$30.20+2.37%$30.22$29.54184,954 shs$970.39 million06/05/2025$29.40$29.50+0.34%$29.57$29.18159,175 shs$947.89 million06/04/2025$29.23$29.40+0.58%$29.72$29.23285,879 shs$944.68 million06/03/2025$29.31$29.23-0.27%$29.74$28.90323,265 shs$939.22 million06/02/2025$29.39$29.31-0.27%$29.44$28.74247,918 shs$941.79 million05/30/2025$29.18$29.39+0.72%$29.50$28.89212,597 shs$944.36 million05/29/2025$28.91$29.18+0.93%$29.35$28.92196,332 shs$937.61 million Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$29.48$28.91-1.93%$29.50$28.78191,853 shs$928.94 million05/27/2025$28.86$29.48+2.15%$29.57$29.18268,741 shs$947.25 million05/26/2025$28.86$28.86$28.99$28.34178,265 shs$927.33 million05/23/2025$28.82$28.86+0.14%$28.99$28.34178,265 shs$927.33 million05/22/2025$29.47$28.82-2.21%$29.41$28.58224,620 shs$926.04 million05/21/2025$29.96$29.47-1.64%$30.05$29.38167,456 shs$946.93 million05/20/2025$29.83$29.96+0.44%$30.40$29.56424,409 shs$962.68 million05/19/2025$30.23$29.83-1.32%$30.16$29.42219,338 shs$958.50 million05/16/2025$29.34$30.23+3.03%$30.53$29.19430,854 shs$971.35 million05/15/2025$29.07$29.34+0.93%$29.80$29.19364,807 shs$942.75 million05/14/2025$29.80$29.07-2.45%$30.17$28.81343,190 shs$934.08 million05/13/2025$29.56$29.80+0.81%$30.13$29.19308,583 shs$957.53 million05/12/2025$28.89$29.56+2.32%$30.46$29.53434,633 shs$949.82 million Related Companies CYTK Stock Chart SRPT Stock Chart KRYS Stock Chart ACAD Stock Chart SWTX Stock Chart ZLAB Stock Chart RARE Stock Chart ACLX Stock Chart ALVO Stock Chart PTGX Stock Chart Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COLL) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
